Correction to: BMC Pulm Med
http://dx.doi.org/10.1186/s12890-019-0954-z
Following publication of the original article [1], the authors flagged that the name of the author ‘Batoul Khoundabi’ had been provided with an incorrect spelling: ‘Batoutl’ was given in place of ‘Batoul’.
This typo has now been corrected in the original article and the corrected version is provided with this correction.
Reference
Malekmohammad, et al. Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy. BMC Pulm Med. 2019;19:188. https://doi.org/10.1186/s12890-019-0954-z.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Malekmohammad, M., Folkerts, G., Kashani, B.S. et al. Correction to: Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy. BMC Pulm Med 19, 197 (2019). https://doi.org/10.1186/s12890-019-0984-6
Published:
DOI: https://doi.org/10.1186/s12890-019-0984-6